By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for “CHOOSE TRANSFORMATION” by Michele H. Bowman, representing Abbott Laboratories. This application was made available to the public on July 01, 2014 (see also Pharmaceutical Companies).
The serial number for this application is 86322397.
The international trademark goods and services class code for this trademark application is 044.
As submitted by the applicant, this trademark application relates to the following goods and services: Medical diagnostics services; molecular diagnostics services; companion diagnostics services; in vitro diagnostics services; medical testing for diagnostic or treatment purposes; providing information relating to diagnosis, monitoring and treatment of medical conditions; providing information in the field of medical diagnostics, molecular diagnostics, companion diagnostics and in vitro diagnostics; consulting in the fields of medical diagnostics, molecular diagnostics, companion diagnostics and in vitro diagnostics.
The owner/registrar information for this application is: Michele H. Bowman, Abbott Laboratories, 100 Abbott Park Road, Ap6c/377, Abbott Park, IL 60064.
Keywords for this news article include: Pharmaceutical Companies, Trademarks, Abbott Laboratories.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Abbott Laboratories’ Trademark Application for “CHOOSE TRANSFORMATION” Filed
By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for
- 1 min Read
- 07.9.2014
If you don't feel that U.S. culture (and much of the world in different ways) is in turmoil, you are not paying attention.
When the Fed begins to lower rates and the greenback cools, I believe dollar-denominated gold will shine. Investment in gold and mining stocks is another matter.
As we say goodbye to 2023, there's a compelling argument to keep your portfolio anchored in growth stocks next year.
BLS and the airlines are measuring different things: CPI allegedly measures average change in prices paid; RASM is an industry efficiency metric.
A weekly five-point roundup of critical events in fintech, the future of finance and the next wave of banking industry transformation.
Crush spreads, which have been trending, are barometers of soybean supply and demand and a real-time indicator of processor profitability.
